If you made any changes in Pure these will be visible here soon.

Research Output 1990 2019

Filter
Review article
2019
2 Citations (Scopus)

Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy

Queirolo, P., Boutros, A., Tanda, E., Spagnolo, F. & Quaglino, P., Jan 1 2019, In : Seminars in Cancer Biology.

Research output: Contribution to journalReview article

Immunotherapy
Melanoma
Neoplasms
Therapeutics
Standard of Care
2018
5 Citations (Scopus)

Effect of age on melanoma risk, prognosis and treatment response

Italian Melanoma Intergroup (IMI), Jan 1 2018, In : Acta Dermato-Venereologica. 98, 7, p. 624-629 6 p.

Research output: Contribution to journalReview article

Melanoma
Therapeutics
Survival
Nevus
Nevi and Melanomas

Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors

Italian Melanoma Intergroup (IMI), Sep 2018, In : Cancer Treatment Reviews. 69, p. 21-28 8 p.

Research output: Contribution to journalReview article

Vitamin D
Melanoma
Vitamin D Deficiency
Immune System Diseases
Up-Regulation
6 Citations (Scopus)

Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors

for the Italian Melanoma Intergroup (IMI), Sep 1 2018, In : Cancer Treatment Reviews. 69, p. 21-28 8 p.

Research output: Contribution to journalReview article

Vitamin D
Melanoma
Vitamin D Deficiency
Immune System Diseases
Up-Regulation
2017
16 Citations (Scopus)
Death Domain Receptors
Renal Cell Carcinoma
Melanoma
Lung Neoplasms
Pharmaceutical Preparations
1 Citation (Scopus)

Il pembrolizumab nel trattamento del melanoma: Aggiornamenti e prospettive

Translated title of the contribution: Pembrolizumab for the treatment of melanoma: Updates and perspectivesSileni, V. C., Mandalà, M. & Queirolo, P., Dec 1 2017, In : Recenti Progressi in Medicina. 108, 12, p. 528-531 4 p.

Research output: Contribution to journalReview article

Melanoma
Immunotherapy
Monoclonal Antibodies
Survival
Therapeutics
2016

Gestione delle reazioni avverse immuno-correlate durante la terapia con inibitori dei checkpoint immunologici

Translated title of the contribution: Management of immune-related adverse events during treatment with immune checkpoint inhibitorsQueirolo, P. & Spagnolo, F., Aug 1 2016, In : Recenti Progressi in Medicina. 107, 8, p. 407-413 7 p.

Research output: Contribution to journalReview article

Guidelines
Paris
Immunotherapy
Monoclonal Antibodies
Therapeutics